儿童烧伤患者芬太尼药代动力学的群体药代动力学特征
本研究旨在描述烧伤面积≥10%总体表面积且需在常规创面护理中使用芬太尼的儿童患者中药代动力学的变异性。研究确认儿童烧伤患者芬太尼药代动力学存在高度变异性,需更大样本进一步研究烧伤、基因多态性等因素对芬太尼疗效和患者结局的影响。
要点
- 儿童烧伤患者芬太尼药代动力学个体间变异大,成人数据外推的给药方案不可靠。
- 以体重为协变量的二室模型可较好描述该人群芬太尼药代动力学。
- 群体清除率7.19 L/h、室间清除率2.16 L/h,中央室分布容积4.01 L、外周室25.1 L。
核心结论
- 儿童烧伤患者芬太尼药代动力学存在高度变异性,个体参数估计值变异很大。
- 以体重为协变量的二室模型最能描述总体人群的芬太尼药代动力学。
- 需更大样本研究烧伤、基因多态性等因素对芬太尼疗效和患者结局的影响。
研究设计与样本
- 记录患者人口学和临床数据,于入院当天及第3天、第7天给药后0、30、60、120、240分钟采血。
- 采用串联液相色谱质谱法测定血清芬太尼浓度,用群体分析估计药代动力学参数。
主要发现
- 二室模型以体重为协变量最佳描述总体人群芬太尼药代动力学。
- 群体清除率为7.19 L/h,室间清除率为2.16 L/h。
- 中央室分布容积为4.01 L,外周室分布容积为25.1 L。
- 个体患者参数估计值存在广泛变异。
临床怎么用
- 儿童烧伤患者芬太尼给药不应直接外推成人剂量方案。
- 临床需关注该人群芬太尼药代动力学的高度个体间变异。
局限性
- 烧伤、基因多态性等因素对芬太尼疗效和患者结局的影响尚需深入探讨。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Opioids are essential first line analgesics for pain management after burn injury. Opioid dosing remains challenging in burn patients, particularly in children, due to the immense variability in efficacy between patients. Opioid pharmacokinetics are altered in burned children, increasing variability and obviating dosing regimens extrapolated from adult-data. The present study aimed to characterize variability in fentanyl pharmacokinetics and identify significant contributors to variability in children with ≥10% total body surface area burn requiring fentanyl during routine wound care. We recorded patient demographics and clinical data. Blood samples were collected following fentanyl administration for pharmacokinetics at time 0, 30, 60, 120, and 240 minutes on day of admission and repeated on days 3 and 7. Serum fentanyl concentrations were quantified using tandem liquid chromatography mass spectrometry. Population analysis was used to estimate pharmacokinetics parameters. Fourteen patients, 1.2-17 years, with burns from 10-50.5% were included in analysis. A two-compartment model with body weight as a covariate best described fentanyl pharmacokinetics for the overall population. The population clearance and intercompartmental clearance were 7.19 and 2.16 L/hour, respectively, and the volume of distribution for the central and peripheral compartments was 4.01 and 25.1 L, respectively. Individual patient parameter estimates had extensive variability. This study confirmed the high variability in pediatric burn patient fentanyl pharmacokinetics and demonstrates similarities and differences to other populations reported in literature. Further research is needed with a larger number of patients to extensively investigate the impact of burns, genetic polymorphisms, and other factors on fentanyl efficacy and patient outcomes.
引用
- Grimsrud KN, Lima KM, Tran NK, et al. Characterizing Fentanyl Variability Using Population Pharmacokinetics in Pediatric Burn Patients. J Burn Care Res. 2020. PMID: 31538188. doi:10.1093/jbcr/irz144
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。